Down-regulation of ER-α36 mRNA in serum exosomes of the patients with hepatocellular carcinoma.

Hui Huang,Zhiyuan Zhou,Hongyan Li,Liang Zhao,Yong Zhang,Chunyan Liu,Changxin Han,Zhidong Wang,Qi Wang,Chunwen Pu,Qiqi Zhang,Wei Zou

doi:10.1002/ctm2.18

Abstract

Listen

Down-regulation of ER-α36 mRNA in serum exosomes of the patients with hepatocellular carcinoma.

Highlights

The results showed that ER-α66 and ER-α36 were expressed in both hepatocellular carcinoma (HCC) and adjacent normal tissue, and located in the cytoplasm and cell membrane of hepatocytes and HCC cells (Figure 1A)
Results showed that plasma estrogen levels were found to be significantly elevated in liver cirrhosis (LC) patients compared with that in CHB patients, and significantly lower in the HCC patients compared with the LC patients (P < .05) (Figure 1B), suggesting that estrogen may be involved in the regulation of the development of HCC
The results showed the area under the curve (AUC) of ER-α66 mRNA was 0.876 (P = .003, 95% CI = 0.732-1.000) and that of ER-α36 mRNA was 0.842 (P = .002, 95% CI 0.669-1.000), indicating that mRNAs of ER-α66 and ER-α36 show good accuracy for the diagnostic of HCC and could be effectively used to distinguish HCC from adjacent tissue (Figure 2I)

Summary

Introduction

We report our study on the expression pattern of estrogen and its receptor variants in serum exosomes of HCC, and provide insightful information for the diagnosis of human HCC. Results showed that plasma estrogen levels were found to be significantly elevated in LC patients compared with that in CHB patients, and significantly lower in the HCC patients compared with the LC patients (P < .05) (Figure 1B), suggesting that estrogen may be involved in the regulation of the development of HCC.

Results

Conclusion